Member Info for mol42

No 4 on list - at least according to long island NY state

https://theislandnow.com/blog-112/best-slimming-gummies/

Extract

In the previous review, we introduced you to Windmill Vitamins and all its amazing work in the nutrition and health supplements world. Since we were looking for effective slimming gummies, we discovered that Windmill’s trusted brand Dietworks, has created another excellent product that helped millions of people lose weight. Besides a more detailed review of the appetite-control gummies, we’re going to tell you some other information regarding Windmill’s work that we missed in our previous section.

Here’s an astonishing fact – Windmill’s products are distributed in over 150,000 retailers worldwide. Even if you can’t find your selected product at your local store, you can use the Store Locator option on Windmill’s website. This tool will direct you to the nearest vendor where you can buy Windmill’s products. Additionally, if the store doesn’t hold some particular item, you can contact customer service, and the representatives will find a way to distribute the product to you. Among those 150,000 merchandisers, there are some world-known names, including Amazon, iHerb, Kmart, Maceys, Target, Walmart, CVS/pharmacy, Brookshire’s, and many more.

Dietworks Appetite Control Gummies

We found countless satisfied customers that used appetite control gummies and lost weight. This product is an excellent appetite suppressant, thanks to its Slimbiome main ingredient.

Pros
A comprehensive assortment of vitamins, minerals, supplements, anti-aging nutrition, etc.
The products are available in multiple forms for better customer convenience
Available in 150,000 retailers across the world
Effective and natural gummies
Key ingredient Slimbiome is a powerful cravings suppressant
The gummies improve digestion and gut health

Cons

The appetite-control gummies are available only in raspberry flavor

mol

word is spreading - this from a couple of hours ago

LPLDL Shows Big Reductions in Multiple Heart Disease Biomarkers for Adults With High LDL

https://www.pharmacytimes.com/view/lpldl-shows-big-reductions-in-multiple-heart-disease-biomarkers-for-adults-with-high-ldl

mol

By way of info

https://listingcenter.nasdaq.com/assets/initialguide.pdf

and a UK company listing will issue

American Depository Receipts (ADRs) are securities that trade in the U.S. but represent a specified number of a non-U.S. company’s shares. ADRs trade and settle like other securities and are priced in U.S. dollars, regardless of the currency of the underlying shares. Only “sponsored” ADRs are eligible to list on Nasdaq, and the issuer of an ADR must register with the SEC and comply with U.S. securities laws, including the periodic reporting requirements.

I experienced a nasdaq listing with vrp and unfortunately that wasn't a success but I had sold up before they delisted on aim
the only "benefit" was very detailed quarterly reports - albeit costly to company - mind one could track prices on different markets at different time zones - lol

I think we should stick to the knitting at the moment but as others have remarked get our message out there in uk

bw all

mol

https://www.youtube.com/watch?v=-5w8oLJ2suE

mol

Hi AquaeSulis01

Not sure if this has been posted before

but a review of seed health's Daily Synbiotic

https://muscleandbrawn.com/reviews/seed-probiotic-review/

mol

and summary now on website

https://optibiotix.com/lpldl-from-probiotix-health-showcases-statistically-significant-reductions-in-multiple-coronary-heart-disease-biomarkers-in-hypercholesterolemic-adults/

Extract

Stephen O’Hara, CEO at OptiBiotix, commented: “The results of this study are remarkable and firmly establish LPLDL® as the probiotic for heart health. Our previous human intervention studies have highlighted LPLDL® as an excellent candidate to reduce cholesterol across different patient groups and countries. Now, with the statistically significant results of our latest study, both partners and consumers can rest assured they are using a science-backed probiotic that not only reduces total cholesterol, but multiple risk factors associated with CHD.

“For the industry, this is a significant step forward for a probiotic that can truly make a difference, demonstrating that LPLDL® champions scientific evidence to deliver impressive results.”

mol

Published Article here

https://www.sciencedirect.com/science/article/pii/S1756464622000093

mol

re RNS

https://www.youtube.com/watch?v=lAQ5hawNqbA

mol

https://www.optibiotix-ir.com/content/news/archive/2018/04-09-18

Think he is referring to the above rns

mol

Announced today in addition to the welcome RNS

https://optibiotix.com/paul-cannings-appointed-head-of-operations-quality-at-optibiotix/

mol

I really don't want to labour this thread - so my last response to same

but this is what our company noted in year end accounts - signed off in Jun 21 - which if our Directors' become aware of anything prior to sign off then obliged to note same.

Risk
The global implications of the economic impact
of COVID-19 could affect sales and profitability.

Mitigation
Although COVID-19 has affected some parts of the
consumer business. The majority of sales are in the business
to business sector across many countries so the impact is very limited.

Going Concern note

Management have considered its forecast of the group’s cash requirements reflecting contracted and anticipated future revenue and the resulting net cash outflows. Management have not seen a material disruption to the business as a result of the COVID-19 outbreak, however,events are being kept under constant review, and remedial action will be taken if the situation demands it.

and

https://www.ifrs.org/issued-standards/list-of-standards/ifrs-15-revenue-from-contracts-with-customers/

ain't rocket science

albeit I may have misunderstood skid post and my response wasn't well worded nor perhaps even necessary

lol

bw all

mol

For those not wishing to click link

Best Probiotic Supplements (2022) Top Gut Health Aid Reviews

3rd on list (albeit top 3 sponsored)

DS-01™? Daily Synbiotic is a probiotic and prebiotic formulated with 24 select strains that have been clinically and scientifically-studied to provide benefits in and beyond the gut, including digestive health, gut immune function, gut barrier integrity, skin health, heart health, and micronutrient synthesis.

Seed’s DS-01™ Daily Synbiotic: The ViaCap® and Probiotic Survivability

Seed’s patented capsule-in-capsule delivery system, ViaCap®, nests an inner probiotic capsule inside an outer prebiotic capsule. Their novel delivery system is engineered to deliver an average of 100% of the DS-01™’s probiotic starting dose through the end of the small intestine for complete delivery to the colon.

In additional to survivability, Seed’s ViaCap® system provides exceptional stability and bacterial viability—results from Seed’s heat and humidity testing indicate remarkable heat and humidity tolerance, specifically in the presence of 10 days of continuous exposure to 100°F heat. It also means there’s no refrigeration required.

Seed’s DS-01™ Daily Synbiotic: Patented, Non-Fermenting Prebiotics

While most prebiotics like FOS, GOS, or inulin, are categorized as dietary fibers Seed’s DS-01™ Microbiota-Accessible Polyphenolic Precursors™? [MAPP] introduces a patented, plant-based, non-fermenting prebiotic compound (punicalagin) concentrated from Indian pomegranate. Punicalagin is further biotransformed by gut bacteria into beneficial metabolites for the body.

Seed’s DS-01™ Daily Synbiotic: Sustainably Delivered, Monthly

Unlike most probiotics packed in plastic, each component of Seed’s Sustainable Refill System 2.0 is designed to protect the DS-01™ Daily Synbiotic and be gentler on the Earth. Monthly refills ship in a certified home-compostable, bio-based pouch for customers to refill a recyclable glass jar. Refills are protected by a sheet of green cell foam, an entirely natural padding made from corn. While most padded mailers are petroleum-based, Seed’s corn form requires 70% less energy and produces 80% less greenhouse gases. It's biodegradeable, backyard-compostable, edible, and dissolves in water (seriously). It also comes with a convenient recyclable travel vial so you never miss a day on the go!

mol

whilst link notes 2020 it actually relates to 2022

https://www.discovermagazine.com/sponsored/best-probiotic-supplements-2020-top-gut-health-aid-reviews

mol

Was there not a number sold within a previous lock-in? Albeit by agreement.

mol

I'm not relating the standard days calculation to our company - our company - in your words shouldn't then raise invoices for a large proportion of its revenue which isn't even due at year end.

I'll pay more attention in future to our policy re sales in the full audited accounts - looks like 180 days plus!

I'm simply pointing out that our company's turnover, as disclosed, hasn't been received in full in our bank account

and , whilst i'm not suggesting window dressing , it doesn't look good

are we "buying sales" ?

mol

the agreement allows for £320,000 to be invoiced on signing with further payments expected, based on services and CTX cell bank vials to be supplied by ReNeuron in the future, although these are contingent on signing a supplemental payment terms agreement which is currently under discussion.

seems to just allow an invoice to be raised for £320,000!

and I'm very disappointed that after all these years

Olav Hellebø, Chief Executive Officer, commented: "We are pleased to announce progress in the technology transfer of the CTX drug product to Fosun and believe this highlights the commitment Fosun has to the programme in Greater China."

anyway i note they now describe themselves to be

a UK-based leader in Stem cell and Exosome Technologies

ren050 perhaps?

mol

Evening martinu

page 8 of the undernoted

https://www.optibiotix-ir.com/docs/librariesprovider35/archive/results/interims-2021.pdf

provides the cashflow snapshot of the story of the first six months and the increase in debtors etc

and £900,936 from sale of sbtx shares was absolutely crucial to our cashflow - otherwise a fund raise may have been on the cards - i expect further sales of sbtx shares in the coming months - which should provide comfort to any investor here that we can call on that asset to provide same - i don't relate it to dilution but just the realisation of an asset to further our greater aims - well done Stephen to have spun it out but not to have hinted at div in specie - albeit the sale of sbtx shares should only be undertaken in the expectation of greater gains within our plc company

We won't be going pear- shaped at least this year 2022 nor I hope thereafter

mol

We await a bit more info re our Indian subsidiary

though good move to form overall

https://www.gov.uk/government/news/uk-launches-india-negotiations-to-kick-off-5-star-year-of-trade

mol

Thx bazzao

I've noted before we should forget about Nasdaq anytime soon and the SBTX dividend in specie was a non-runner really ( i commented same on another BB years ago which has now become extinct!) and also will be regarding any other spin-outs which Stephen a number of years ago said was the overall strategy of optibiotix plc

I share your frustration re sweetbiotix and any evening which i have time to doodle (like this evening) I do spend some time trying to gain further info re same

I look forward to update re year end accounts - and will be especially interested in trade debtor figure - because 6 mths revenue of £1,076,044 and Trade and other receivables of £1,285,689 was of some concern to me.

The full audited accounts, once published, do give a bit more detail ie

year to dec 2020

Turnover was £1,523,247 and trade receivables £512,437 which was bad enough (ie one third of year's revenue hadn't been received - in our bank - by year end)

mol

further to

https://nutraceuticalbusinessreview.com/news/article_page/OptiBiotix_Health_announces_CEO_for_subsidiary/175894

I would have used our RNS but thought a nice picture of Rene

and this within

Following the appointment, Dr Frederic Narbel will move from his position as director of the OptiBiotix board and managing director of the functional fibres division to a more strategic role as Non-Executive Director of OptiBiotix in June.

“I would like to thank Fred for his ongoing contribution to OptiBiotix,” said O’Hara. “He has been instrumental to the commercial success of SlimBiome with many of our partners around the world. The leadership team and board look forward to him taking a more strategic role in the business later this year.”

Looks like he has now left completely from 31/12/ 2021

that strategic role didn't last long!

https://find-and-update.company-information.service.gov.uk/company/07992608/filing-history

mol